{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:52:00Z","timestamp":1790419920155,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.04.082","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T07:30:16Z","timestamp":1497943816000},"page":"4470-4474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"PA","title":["AIDS, Avian flu, SARS, MERS, Ebola, Zika\u2026 what next?"],"prefix":"10.1016","volume":"35","author":[{"given":"Leslie A.","family":"Reperant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.082_b0005","first-page":"49","article-title":"The importance of understanding the human-animal interface. From early hominins to global citizens","volume":"365","author":"Reperant","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.04.082_b0010","doi-asserted-by":"crossref","first-page":"aad2622","DOI":"10.1126\/science.aad2622","article-title":"The Anthropocene is functionally and stratigraphically distinct from the Holocene","volume":"351","author":"Waters","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.082_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3184\/003685008X284628","article-title":"The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world","volume":"91","author":"Sanders","year":"2008","journal-title":"Sci Prog"},{"key":"10.1016\/j.vaccine.2017.04.082_b0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.coviro.2012.02.010","article-title":"Rinderpest eradication: lessons for measles eradication?","volume":"2","author":"de Swart","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2017.04.082_b0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/17130","article-title":"Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes","volume":"397","author":"Gao","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0030","unstructured":"World_Health_Organization. (ed. World_Health_Organization), 2017."},{"key":"10.1016\/j.vaccine.2017.04.082_b0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.082_b0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"Dalgleish","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0045","unstructured":"Public_Health_Service, D.o.H.a.H.S., 1987."},{"key":"10.1016\/j.vaccine.2017.04.082_b0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0055","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.vaccine.2012.04.049","article-title":"Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans","volume":"30","author":"Reperant","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.082_b0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.082_b0065","doi-asserted-by":"crossref","unstructured":"Reperant, L.A., Rimmelzwaan, G. & Osterhaus, A.D.M.E. Recent advances in influenza vaccination. F1000Prime Rep 6, 47- (2014).","DOI":"10.12703\/P6-47"},{"key":"10.1016\/j.vaccine.2017.04.082_b0070","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0075","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa0907650","article-title":"Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine","volume":"361","author":"Clark","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0080","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa0907413","article-title":"Response to a monovalent 2009 influenza A (H1N1) vaccine","volume":"361","author":"Greenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0085","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3201\/eid1511.090868","article-title":"Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China","volume":"15","author":"Chen","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.082_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"375","author":"Liang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.04.082_b0095","doi-asserted-by":"crossref","unstructured":"Reperant, L.A., Rimmelzwaan, G.F. & Osterhaus, A.D. Advances in influenza vaccination. F1000Prime Rep 6, 47, 2014.","DOI":"10.12703\/P6-47"},{"key":"10.1016\/j.vaccine.2017.04.082_b0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000149300","article-title":"Filoviridae: a taxonomic home for Marburg and Ebola viruses?","volume":"18","author":"Kiley","year":"1982","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.04.082_b0105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/v6041759","article-title":"Filoviruses in bats: current knowledge and future directions","volume":"6","author":"Olival","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.04.082_b0110","unstructured":"Chan, M. in Women in Science Lecture Series (ed. World_Health_Organization) (London School of Hygiene and Tropical Medicine, 2015)."},{"key":"10.1016\/j.vaccine.2017.04.082_b0115","doi-asserted-by":"crossref","first-page":"e1006037","DOI":"10.1371\/journal.ppat.1006037","article-title":"Fighting Ebola: a window for vaccine re-evaluation?","volume":"13","author":"Chappell","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.04.082_b0120","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0125","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.04.082_b0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.082_b0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm1001","article-title":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques","volume":"10","author":"Haagmans","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.vaccine.2017.04.082_b0160","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.082_b0165","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.082_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","article-title":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26","volume":"16","author":"Wang","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.04.082_b0180","unstructured":"World_Health_Organization, 2017."},{"key":"10.1016\/j.vaccine.2017.04.082_b0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.082_b0190","unstructured":"World_Health_Organization, 2017."},{"key":"10.1016\/j.vaccine.2017.04.082_b0195","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.vaccine.2016.03.076","article-title":"Status of research and development of vaccines for chikungunya","volume":"34","author":"Smalley","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.082_b0200","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3201\/eid1509.090442","article-title":"Zika virus outside Africa","volume":"15","author":"Hayes","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.082_b0205","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJMp1602708","article-title":"Zika virus as a cause of neurologic disorders","volume":"374","author":"Broutet","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.082_b0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14760584.2016.1192474","article-title":"Development of a Zika vaccine","volume":"15","author":"Tripp","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.04.082_b0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1098\/rstb.2001.0889","article-title":"Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence","volume":"356","author":"Cleaveland","year":"2001","journal-title":"Philos Trans Roy Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2017.04.082_b0220","first-page":"281","article-title":"One health: the Hong Kong experience with avian influenza","volume":"365","author":"Sims","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.04.082_b0225","doi-asserted-by":"crossref","first-page":"e42689","DOI":"10.1371\/journal.pone.0042689","article-title":"A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent nipah virus transmission in Bangladesh","volume":"7","author":"Khan","year":"2012","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T21:44:06Z","timestamp":1659131046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17305832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIDS, Avian flu, SARS, MERS, Ebola, Zika\u2026 what next?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}